ENDRA Life Sciences Balance Sheet Health
Financial Health criteria checks 4/6
ENDRA Life Sciences has a total shareholder equity of $6.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $8.4M and $1.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.75m |
| Equity | US$6.60m |
| Total liabilities | US$1.77m |
| Total assets | US$8.38m |
Recent financial health updates
Recent updates
ENDRA to submit FDA De Novo request for liver disease monitoring system in coming weeks
Sep 29ENDRA Life Sciences receives European patent for TAEUS system
Aug 24Endra Life Sciences Q2 2022 Earnings Preview
Aug 12We're A Little Worried About ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate
Aug 08
We're Keeping An Eye On ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate
Nov 18We Think ENDRA Life Sciences (NASDAQ:NDRA) Needs To Drive Business Growth Carefully
Jul 19ENDRA Life Sciences names Irina Pestrikova Principal Financial Officer
Jun 15ENDRA Life Sciences granted 13th U.S. Patent for its TAEUS platform technology
Jan 13ENDRA Life Sciences renews GE Healthcare collaboration agreement
Dec 21Endra Life prices $5M-share offering
Dec 16Endra Life Sciences EPS beats by $0.02
Nov 16Financial Position Analysis
Short Term Liabilities: NDRA's short term assets ($5.0M) exceed its short term liabilities ($814.0K).
Long Term Liabilities: NDRA's short term assets ($5.0M) exceed its long term liabilities ($960.4K).
Debt to Equity History and Analysis
Debt Level: NDRA is debt free.
Reducing Debt: NDRA has no debt compared to 5 years ago when its debt to equity ratio was 46.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NDRA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NDRA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.3% each year